Atlas Trials

Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer

Clinical trial NCT01661972 · COMPLETED

Trial details

NCT number
NCT01661972
Sponsor
John Strickler, M.D.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2012-08-01
Primary completion
2016-06-12
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.